Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Outlook Therapeutics Inc (OTLK)

Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Have a Relaxing Holiday Season Baystreet - Fri Dec 20, 2:13PM CST

Monday U.S. Economic Lookahead Consumer confidence (Dec.) Featured Earnings Limoneira ...

OTLK : 1.4400 (+3.60%)
PFX : 49.70 (+0.61%)
LMNR : 26.30 (+2.49%)
CVM : 0.7299 (-4.60%)
Outlook Therapeutics Implements Organizational Streamlining Measures Ahead of LYTENAVA™ Launch in EU and UK Quiver Quantitative, Inc. - Sat Dec 14, 1:56AM CST

Outlook Therapeutics announces strategic workforce reduction to enhance resource allocation for launching LYTENAVA™ in Europe and UK.Quiver AI SummaryOutlook Therapeutics, Inc. has announced strategic...

OTLK : 1.4400 (+3.60%)
Outlook Therapeutics® Streamlines Operations GlobeNewswire - Fri Dec 13, 3:30PM CST

OTLK : 1.4400 (+3.60%)
OTLKW : 0.03 (-1.96%)
Outlook Therapeutics® Announces NICE Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD GlobeNewswire - Wed Dec 4, 7:05AM CST

OTLK : 1.4400 (+3.60%)
OTLKW : 0.03 (-1.96%)
Outlook Therapeutics Announces Leadership Change; Russell Trenary Steps Down as CEO Quiver Quantitative, Inc. - Wed Dec 4, 1:52AM CST

Outlook Therapeutics announces CEO transition; Lawrence Kenyon appointed Interim CEO as company prepares for LYTENAVA™ launch in 2025.Quiver AI SummaryOutlook Therapeutics, Inc. announced that Russell...

OTLK : 1.4400 (+3.60%)
Outlook Therapeutics® Announces Executive Leadership Transition GlobeNewswire - Tue Dec 3, 3:30PM CST

OTLK : 1.4400 (+3.60%)
OTLKW : 0.03 (-1.96%)
Outlook Therapeutics Announces Preliminary Results from NORSE EIGHT Trial and Plans for BLA Resubmission in Early 2025 Quiver Quantitative, Inc. - Wed Nov 27, 4:16PM CST

Outlook Therapeutics reports preliminary results for ONS-5010 in wet AMD, planning BLA resubmission in early 2025.Quiver AI SummaryOutlook Therapeutics, Inc. announced preliminary topline results from...

OTLK : 1.4400 (+3.60%)
Outlook Therapeutics® Announces Preliminary Topline Results of NORSE EIGHT Clinical Trial GlobeNewswire - Wed Nov 27, 5:50AM CST

OTLK : 1.4400 (+3.60%)
OTLKW : 0.03 (-1.96%)
Outlook Therapeutics® to Present at the Guggenheim Healthcare Innovation Conference GlobeNewswire - Wed Nov 6, 7:05AM CST

OTLK : 1.4400 (+3.60%)
OTLKW : 0.03 (-1.96%)
Outlook Therapeutics® Participates in a Virtual Investor CEO Connect Segment GlobeNewswire - Thu Oct 17, 8:00AM CDT

OTLK : 1.4400 (+3.60%)
OTLKW : 0.03 (-1.96%)

Barchart Exclusives

Is It Time to Sell This Second-Fiddle AI Stock Before 2025? Barchart - 38 minutes ago
Bank of America has cut its rating on AMD while lowering its price target. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot